JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2016, 65(1):22-27 | DOI: 10.36290/csf.2016.004

Influence of the mesh of extrusion dies on the properties of cores intended for the preparation of pellets with controlled glucose release

Sylvie Pavloková1, Aleš Franc1,*, Jan Muselík1, Dana Sabadková1, Pavlína Kopecká1, David Neumann2
1 Ústav technologie léků, Farmaceutická fakulta, Veterinární a farmaceutická univerzita, Brno, Česká republika
2 Dětská klinika 1. LF UK a FN, Hradec Králové, Česká republika

Diabetes mellitus and its compensation are accompanied by serious complications. One of them is hypoglycaemia, which occurs in patients treated with insulin and/or certain peroral antidiabetics. Hypoglycaemic episodes can be prevented by a dosage form with controlled release of glucose. The pellet cores of four compositions and three different sizes corresponding to the diameter of extrusion screen mesh (0.6, 0.8, and 1.0 mm) were prepared for this purpose. The cores contain 75-80% of glucose combined with one of the following osmotically or swellable active agents: croscarmellose sodium (ADS), a mixture of microcrystalline cellulose and carmellose sodium Avicel RC 591 (RC), polyethylene glycol 6000 (PEG), and carboxymethyl starch (CMS). The cores were prepared by extrusion-spheronization and are intended for subsequent coating by a semipermeable membrane based on ethylcellulose. The aim of the work was to statistically evaluate the results of the physical evaluation of the pellets which were prepared and evaluated in previously published papers. The results are processed in the form of a meta-analysis using principle component analysis. The physical characteristics of the individual pellet sizes were different among themselves. Although the same compositions and manufacturing methods were used for all the pellets sizes, the cores produced through a 0.6 and 0.8 mm mesh screens showed similar properties while the properties of cores produced through a 1.0 mm mesh screen were rather different.

Keywords: hypoglycemia; delayed release; glucose; principal component analysis PCA; meta-analysis of data

Received: December 13, 2015; Accepted: January 4, 2016; Published: January 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavloková S, Franc A, Muselík J, Sabadková D, Kopecká P, Neumann D. Influence of the mesh of extrusion dies on the properties of cores intended for the preparation of pellets with controlled glucose release. Čes. slov. farm. 2016;65(1):22-27. doi: 10.36290/csf.2016.004.
Download citation

References

  1. American Diabetes Association Workgroup on Hypoglycaemia. 2005.
  2. Fisher M., Heller S. R. Hypoglycaemia in clinical diabetes. 2nd ed. Chichester, UK: John Wiley & Sons 1999.
  3. Fanelli C. G., Porcellati F., Pampenelli S., Bolli G. B. Insulin therapy and hypoglycaemia: the size of the problem. Diabetes Metab. Res. Rev. 2004; 20(2), 32-42. Go to original source... Go to PubMed...
  4. Ryan C., Gurtunca N., Becker D. Hypoglycemia: a complication of diabetes therapy in children. Pediatr. Clin. North Am. 2005; 52, 1705-1733. Go to original source... Go to PubMed...
  5. Franc A., Dvořáčková K., Muselík J., Žvaková M., Slováková V., Vetchý D., Sabadková D., Neumann D., Goněc R. Formulation of cores for the controlled release of glucose for prevention of hypoglycemia in diabetes patients. Čes. slov. Farm. 2014; 63, 206-212. Go to original source...
  6. Heng P. W., Chan L. W., Chew S. H. Mechanism of pellet coat rupture and its effect on drug release. Chem. Pharm. Bull. 1999; 47(7), 939-943. Go to original source... Go to PubMed...
  7. Sabadková D., Franc A., Muselík J., Neumann D. Coated pellets based on delayed release glucose as prevention of hypoglycemic episodes. Acta Pharmaceut. 2016 (v tisku). Go to original source...
  8. Franc A., Muselík J., Sabadková D., Neumann D. Preparation of pellets with controlled release of glucose as prevention of hypoglycaemia in paediatric patients. Eur. J. Pharm. Sci. 2015; 75, 72-80. Go to original source... Go to PubMed...
  9. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2015. https://www.r-project.org/
  10. Franc A., Sabadková D., Neumann D., Pavloková S., Kopecká P., Muselík J. Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release. Pharm. Dev. Technol. 2015; 1-8. Go to original source... Go to PubMed...
  11. Council of Europe. European Pharmacopoeia, 8th edition. Council of Europe, Strasbourg 2013.
  12. Rabišková M. Technologické parametry lékových mikroforem, jejich význam a metody jejich stanovení. Čes. slov. Farm. 1996; 45, 177-179.
  13. Rabišková M., Masteiková R., Chalupová Z., Dvořáčková K. Lékové formy a biofarmacie: II. Brno: Veterinární a farmaceutická univerzita 2009.
  14. Podczeck F., Rahman S. R., Newton J. M. Evaluation of a standardised procedure to assess the shape of pellets using image analysis. Int. J. Pharm. 1999; 192, 123-138. Go to original source... Go to PubMed...
  15. Chopra R. F., Podczeck J. M., Alderborn G. The influence of pellet shape and film coating on the filling of pellets into hard shell capsules. Eur. J. Pharm. Biopharm. 2002; 53, 327-333. Go to original source... Go to PubMed...
  16. Rhodes C. T., Porter S. C. Coatings for controlled-release drug delivery systems. Drug. Dev. Ind. Pharm. 1998; 24, 1139-1154. Go to original source... Go to PubMed...
  17. Saary M. Joan. Radar plots: a useful way for presenting multivariate health care data. J. Clin. Epidemiol. 2008; 61(4), 311-317. Go to original source... Go to PubMed...
  18. Wehrens, R. Chemometrics with R. 1st ed. Heidelberg: Springer 2011. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.